Clinical Care:

Alsaggaf R, St George DMM, Zhan M, Pfeiffer RM, Wang Y, Wagner KR, Greene MH, Amr S, Gadalla SM.  Cancer risk in myotonic dystrophy type 1:  evidence of a role for disease severity.  JNCI Cancer Spectr 2018, Nov2 (4):  pky052.  PMID:  30556050

Trout CJ, Case LE, Clemens PR, McArthur A, Noritz G, Ritzo M, Wagner KR, Vroom E, Kennedy A.  A transition toolkit for Duchenne muscular dystrophy.  Pediatrics 2018 Oct; 142(Suppl 2):  S110-S117.  PMID 30275255.

Buddhe S, Cripe L, Friedland-Little JU, Kertesz N, Eghtesady P, Finder J, Hor K, Judge DP, Kinnett K, McNally EM, Raman S, Thompson WR, Wagner KR, Olson AK.  Cardiac management of the patient with Duchenne muscular dystrophy.  Pediatrics 2018 Oct; 142 (Suppl 2):  S72-S81.  PMID 30275251

Leigh F, Ferlini A, Biggar D, Bushby K, Finkel R, Morgenroth LP, Wagner KR.  Neurology care, diagnostics, and emerging therapies of the patient with Duchenne muscular dystrophy.  Pediatrics 2018 Oct; 142 (Supp 2):  S5-S16.  PMID:  30275245. 

Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbuahg D, Case LE, Clemens PR, Hadjiyannakis S, Pandya S, Street N, Tomezsko J, Wagner KR, Ward LM, Weber DR, DMD Care Considerations Working Group.  Diagnosis and management of Duchenne muscular dystrophy, part 1:  diagnosis and neuromuscular, rehabilitation, endocrine and gastrointestinal and nutritional management.  Lancet Neurol.  2018 Mar ; 17 (3):  251-267.  PMIDL  29395989. 

Chagarlamudi H, Corbett A, Stoll M, Bibat G, Grosmann C, Stock CM, Stinson N, Shapiro J, Wagner KR.  Bone health in facioscapulohumeral muscular dystrophy:  A cross-sectional study.  Muscle Nerve 2017, 55(3): 333-337.  PMID 28214289.

Tanawuttiwat T, Wagner KR, Tomaselli G, Nazarian S.  Left ventricular dysfunction and conduction disturbances in patient with myotonic muscular dystrophy type I and II.  JAMA Cardiol.  2017, 2(2): 225-228.

Clinical Research:

Sun C, Choi IY, Rovira Gonzalez YI, Andersen P, Talbot CC Jr, Iyer SR, Lovering RM, Wagner KR*, Lee G*. Duchenne muscular dystrophy hiPSC-derived myoblast drug screen identifies compounds that ameliorate disease in mdx mice. JCI Insight. 2020 Apr 28. pii: 134287. doi: 10.1172/jci.insight.134287. [Epub ahead of print] PMID:32343677 * co-corresponding authors

Wagner KR, Abdel-Hamid HZ, Mah JK, Campbell C, Muntoni F, Takeshima Y, McDonald CM, Kostera-Pruszczyk A, Karachunski P, Butterfield RJ, Mercuri E, Fiorillo C, Bertini ES, Tian C, Statland J, Sadowsky AB, Purohit VS, Sherlock SP, Palmer JP, Binks M, Charnas L, Maraffino S, Wong BL. Randomized phase 2 trial and open-label extension of domagrozumab in Duchenne muscular dystrophy. Neuromuscular Disorders 2020.

Leung DG, Bocchieri AE, Ahlawat S, Jacobs MA, Parekh VS, Braverman V, Summerton K, Mansour J, Bibat G, Morris C, Marrafino S, Wagner KR. Longitudinal functional and imaging outcome measures in FKRP limb-girdle muscular dystrophy. BMC Neurology 2020.

Leung DG.  Magnetic resonance imaging in facioscapulohumeral muscular dystrophy.  Muscle Nerve 2018 Jun; 57 (6) 872-874.  PMID 29329515. 

Leung DG, Wang, X, Barker PB, Carrino JA, Wagner KR.  Multivoxel proton magnetic resonance spectroscopy in facioscapulohumeral muscular dystrophy.  Muslce Nerve 2018 Ju; 57 (6) 958-963.  PMID 29266323. 

Eichinger K, Heatwole C, Heininger S, Stinson N, Matichak Stock C, Grosmann C, Wagner KR, Tawil R, Statland JM, FSHD Clinical Trials Research Network.  Validity of the Six Minute Walk Test in Facioscapulohumeral muscular dystrophy.  Muscle Nerve 2016.  PMID 27421252.

Leung D, Carrino J, Wagner KR, Jacobs, M.  Whole-body MRI evaluation of facioscapulohumeral muscular dystrophy.  Muscle Nerve. 2015.  Jan 16. Doi: 10.1002/mus/24569 [Epub ahead of print]. PMID 25641525

Leung D, Herzka DA, Thompson WR, He B, Bibat G, Tennekoon G, Russell SD, Schuleri KH, Lardo AC, Kass DA, Thompson RE, Judge DP, Wagner KR.  Sildenafil does not improve cardiomyopathy in Duchenne/Becker Muscular Dystrophy.  Ann Neurol. 2014, 76(4): 541-549. PMID: 25042693

Statland JM, McDermott MP, Heatwole C, Martens WB, Pandya S, van der Kooi EL, Kissel JT, Wagner KR, Tawil R.  Reevaluating measures of disease progression in facioscapulohumeral muscular dystrophy.  Neuromuscul Disord. 2013; 239(4):306-12. PMID: 23406877.

Laboratory Research:

Gilbert-Honick J, Ginn B, Zhang Y, Salehi S, Wagner KR, Mao HQ, Grayson WL.  Adipose-derived stem/stromal cells on electrospun fibrin microfiber bundles enable moderate muscle reconstruction in a volumetric muscle loss model.  Cell Transplant.  2018 Oct 9:  963689718805370.  PMID:  30298751.

Estrellas KM, Chung L, Cheu LA, Sadtler K, Majumdar S, Mula J, Wolf MT, Elisseeff JH, Wagner KR.  Biological scaffold-mediated delivery of myostatin inhibitor promotes a regenerative immune response in an animal model of Duchenne muscular dystrophy.  J Biol Chem.  2018 Oct 5, 293 (4): 15594-15605.  PMID 30139748. 

Chen JCJ, King OD, Zhang Y, Clayton NP, Spencer C, Wentworth BM, Emerson CP, Wagner KR. Morpholino-Mediated Knockdown of DUX4 Towards Facioscapulohumeral Muscular Dystrophy Therapeutics.  Molecular Therapy 2016, 24(8):1405-11.  PMID 27378237.

Choudhury SR, Fitzpatrick Z, Harris, AF, Maitland SA, Ferreira JS, Zhang Y, Ma S, Sharma RB, Ray-Edwards HL, Johnson JA, Johnson AK, Alonso LC, Punzo, C, Wagner KR, Maguire CA, Kotin RM, Martin DR, Sena-Esteves M.  In vivo selection yields AAV-B1 capsids for CNS and muscle gene therapy.  Mol Ther. 2016, 24 (7): 1247-57. PMID 27117222.

Choi IY, Lim H, Estrellas K, Mula J, Cohen T, Zhang Y, Donnelly C, Richard JP, Kin Y, Kim H, Kazuki Y, Oshimura M, Rothstein J, Maragakis N, Wagner KR, Lee G. Concordant but varied phenotypes among patient-specific myoblasts of Duchenne muscular dystrophy revealed by human iPSC-based model.  Cell Reports  2016, 15(1): 2301-12. PMID 27239027. 

Kornegay JN, Bogan DJ, Bogan JR, Dow JL, Wang J, Fan Z, Liu N, Warsing L, Grange RW, Ahn M, Balog-Alvarez J, Cotton SW, Willis MS, Brinkmeyer-Langford C, Zhu H, Palandra J, Morris CA, Styner MA, Wagner KR.  Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures.  Skeletal Muscle  2016, 6:14.  PMID:27047655 

Moyer AL and Wagner KR.  Mammalian Mss51 is a skeletal muscle-specific gene modulating cellular metabolism.  J Neuromusc Disease.  2015, 2(4):  371-385. PMID26634192.  

Zhang Y, King OD, Rahimov, F, Jones TI, Ward CW, Kerr JP, Liu N, Emerson CP Jr, Kunkel LM, Partridge TA, Wagner KR.  Human skeletal muscle xenograft as a new preclinical model for muscle disorders.  Hum Mol Genet. 2014, 23 (12): 3180-3188.  PMID 24452336.

Additional Resources:

The Center for Genetic Muscle Disorders has compiled a list of helpful related resources as a service to our users. These links are intended to be used for informational purposes only.